Disclosures for "Patient Preferences for Attributes of Advanced Migraine Prevention Medications: Findings from a Discrete Choice Experiment")
-
Dr. Schwedt has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Allergan. Dr. Schwedt has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biohaven. Dr. Schwedt has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Click Therapeutics. Dr. Schwedt has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Eli Lilly. Dr. Schwedt has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Lundbeck. Dr. Schwedt has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Schwedt has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ipsen. Dr. Schwedt has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Tonix Pharma. Dr. Schwedt has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Satsuma. Dr. Schwedt has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biodelivery Science. Dr. Schwedt has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Abbvie. Dr. Schwedt has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Axsome. Dr. Schwedt has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Collegium. Dr. Schwedt has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Linpharma. Dr. Schwedt has stock in Aural Analytics. Dr. Schwedt has stock in Nocira. The institution of Dr. Schwedt has received research support from Amgen. The institution of Dr. Schwedt has received research support from National Institutes of Health. The institution of Dr. Schwedt has received research support from United States Department of Defense. The institution of Dr. Schwedt has received research support from Patient Centered Outcomes Research Institute. The institution of Dr. Schwedt has received research support from SPARK Neuro. The institution of Dr. Schwedt has received research support from Henry Jackson Foundation. Dr. Schwedt has received intellectual property interests from a discovery or technology relating to health care. Dr. Schwedt has received publishing royalties from a publication relating to health care.
-
Dr. Martin has received personal compensation for serving as an employee of Cerner Enviza. The institution of Dr. Martin has received research support from Lundbeck LLC.
-
Steven Kymes has received personal compensation for serving as an employee of Lundbeck. Steven Kymes has received research support from Emmes Corporation.
-
Dr. Talon has nothing to disclose.
-
Ms. Lee has received personal compensation for serving as an employee of Lundbeck A/S.
-
Dr. Cady has received personal compensation for serving as an employee of Lundbeck. Dr. Cady has stock in Alder Biopharmaceutical.
-
Divya Asher has received personal compensation for serving as an employee of Lundbeck. Divya Asher has received personal compensation for serving as an employee of AbbVie.
-
Meghana Karnik-Henry has received personal compensation for serving as an employee of Lundbeck.
-
Ms. Mulvihill has received personal compensation for serving as an employee of Cerner Enviza, an Oracle Company.
-
Ms. Bates has nothing to disclose.
-
Ms. Beusterien has received personal compensation for serving as an employee of Cerner Enviza.